- PDF version
-
Translations
Galbiopharm
About us
Galbiopharm is the University Platform from joint research center (UMR 454) “Microbiology, Digestive Environment and Health” associated with the Université Clermont Auvergne (UCA).
The Galbiopharm platform provides the scientific community with a range of state-of-the-art technologies to i) develop conventional or multiparticulate drug delivery systems obtained from wet granulation, compression, ionic gelification/extrusion or spray-drying and ii) characterize in vitro (dissolution, permeability), ex vivo (absorption) and in vivo (pharmacokinetic) biopharmaceutic properties of new drug delivery systems.
The Galbiopharm platform provides the scientific community with a range of state-of-the-art technologies to i) develop conventional or multiparticulate drug delivery systems obtained from wet granulation, compression, ionic gelification/extrusion or spray-drying and ii) characterize in vitro (dissolution, permeability), ex vivo (absorption) and in vivo (pharmacokinetic) biopharmaceutic properties of new drug delivery systems.
Our services
- Development of multiparticulate drug delivery systems by ionic gelification/extrusion method (alginate/chitosan) with Encapsulator® for entrapment of active pharmaceutical ingredients or probotics,
- Development of multiparticulate drug delivery systems by spray-drying for entrapment of active pharmaceutical ingredients or probotics,
- Development of sustained release drug dosage from by wet granulation and compression processes,
- Characterization of physicochemical properties of new druf delivery system by optical microscopy, FTIR spectroscopy, particle size measurement by laser scattering,
- In vitro, ex vivo and in vivo characterization of biopharmaceutic properties by dissolution systems (USP1, USP2 and USP4), cell cultures (Caco-2, T84, HT-29 MTX), isolated organs (rat) and animals (pharmacokinetic).
Equipments
- Encapsulator ®
- Spraydryer
- Mastersizer®
- FTIR Spectroscopy
- USP1/2 dissolution systems
- USP4 dissolution system
- Cell cultures facilities
- Animal testing facilities
- HPLC DAD
Some of our achievements
- Aptys pharmaceuticals : biopharmaceutic characterization (dissolution / permeability studies)
- Biocorp : biopharmaceutic characterization (dissolution study)
- Recoverlab : biopharmaceutic characterization (dissolution study with probiotics)
- CEVA : biopharmaceutic characterization (dissolution study)
- Substipharm : biopharmaceutic characterization (dissolution study)
- Sanofi : biopharmaceutic characterization (dissolution / permeability studies)
- Pileje : biopharmaceutic characterization (dissolution study)
- 4D Pharma : physicochemical characterization
- Lallemand : multiparticulate drug dosage form development
Contacts
Scientific leader
Address
MEDIS
Bâtiment CBRV
Facultés de Médecine et Pharmacie
28, place Henri DUNANT
63001 Clermont-Ferrand, france
Bâtiment CBRV
Facultés de Médecine et Pharmacie
28, place Henri DUNANT
63001 Clermont-Ferrand, france
In the same section
- Social Science
- Intelligent cars - Wave - Connection
- Structural Materials - Surface Treatments
- Physico-Chemical Analysis
-
Biology and Health Technologies
- 3D Print
- Artificial Mastication Advanced Machine (AM2)
- Biological Sample Irradiation (PAVIRMA)
- Cell Imaging Service (CICS)
- Chromatography & lipid analysis facility
- Cican'Auv
- Clermont Confocal Imaging (CLIC)
- Clinical Research Division of Jean PERRIN Comprehensive Cancer Center
- Culturomic
- Cytometry, Sort & Transmission Electronic Microscopy (CYSTEM)
- Digestive Environment Simulation (Digest-IV)
- EVALSEM
- Fly Facility
- Galbiopharm
- Gene Capture
- High Throughput Genotyping and Sequencing in Auvergne (Gentyane)
- In Vivo Imaging Auvergne (IVIA)
- Laser Microdissection Platform (LMD)
- PEPS
- Platform of Exploration of Metabolism (PFEM)
- Microscopy - Imaging
- Environmental Technologies and Geomatics